The current role of Gamma Knife radiosurgery in the management of intracranial haemangiopericytoma

Acta neurochirurgica
Alfio SpinaPietro Mortini

Abstract

Haemangiopericytomas (HPCs) are rare tumours characterised by aggressive behaviour with tendency to local recurrence and to metastasise. WHO grade II and grade III tumours show different progression-free survival and overall survival rates. Gross total tumour resection is still considered the treatment of choice. Adjuvant radiation therapies represent an option in the treatment strategy regardless the extent of resection. Based on this consideration, Gamma Knife radiosurgery has been introduced either as a primary treatment or as an adjuvant treatment for residual or recurrent tumours. A systematic search was performed on PubMed, Web of Science and Google Scholar for clinical series reporting Gamma Knife radiosurgery, Cyberknife and Linear Accelerator (LINAC) for the management of intracranial HPCs. Fourteen studies focusing on the effects of Gamma Knife radiosurgery for intracranial HPCs were included. Four studies reported data on Cyberknife radiosurgery and LINAC. A total of 208 patients harbouring 366 tumours have been reported. Patient's features, radiosurgical treatment characteristics and follow-up data of the pertinent literature have been critically revised. Gamma Knife radiosurgery and the other radiosurgical techniqu...Continue Reading

References

Jan 1, 1995·Journal of Neurosurgery·G A YounisJ M Bruner
Jul 18, 2000·Acta neurochirurgica·B R PayneL Steiner
Sep 6, 2001·Acta neurochirurgica·J F AlénJ R Ricoy
Jan 5, 2002·Japanese Journal of Clinical Oncology·M SomeyaM Hareyama
Sep 18, 2002·Neurosurgery·Jason SheehanL Dade Lunsford
Mar 14, 2003·Surgical Neurology·Jeong Hoon KimByung Duk Kwun
Jan 27, 2005·Neurosurgical Focus·Steven D Chang, Gordon T Sakamoto
Oct 14, 2005·Cancer·Stephanie E CombsDaniela Schulz-Ertner
Jan 5, 2006·Neurosurgical Review·K N FountasJ R Smith
Aug 30, 2008·International Journal of Radiation Oncology, Biology, Physics·Hideyuki KanoL Dade Lunsford
Oct 25, 2008·Progress in Neurological Surgery·Yoshiyasu Iwai, Kazuhiro Yamanaka
Feb 19, 2009·Stereotactic and Functional Neurosurgery·Shibin SunChongcheng Wang
Apr 4, 2009·Journal of Hematology & Oncology·Nicholas D CoppaWalter C Jean
Jan 20, 2010·Journal of Neuro-oncology·Jin Wook KimHee-Won Jung
Apr 7, 2010·Journal of Neurosurgery·Martin J RutkowskiAndrew T Parsa
Aug 3, 2010·Journal of Neurosurgery·Marco SchiaritiNeil Kitchen
Jan 29, 2011·Langenbeck's Archives of Surgery·Simon SchimmackIrvin M Modlin
Jun 8, 2011·Journal of Hematology & Oncology·Anand VeeravaguSteven D Chang
Sep 16, 2011·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Martin J RutkowskiAndrew T Parsa
Jul 25, 2012·Journal of Neurological Surgery. Part A, Central European Neurosurgery·Michelle J ClarkeMichael J Link
Aug 8, 2012·International Journal of Radiation Oncology, Biology, Physics·Alexander M StessinBaoqing Li
Nov 16, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Rohan RamakrishnaManuel Ferreira
Nov 19, 2013·World Neurosurgery·Angelina Graziella MeloneAntonio Santoro
Jan 1, 2012·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Cristina PradoFerran Guedea
Jul 10, 2014·Journal of Neuro-oncology·William R CopelandBruce E Pollock

❮ Previous
Next ❯

Citations

Oct 19, 2016·Expert Review of Anticancer Therapy·David Mathieu
Jun 24, 2017·Journal of Neurosurgery·Caroline ApraMichel Kalamarides

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.